Hence, although it is intuitive that p16Ink4A acts as a cell cycle inhibitor in the nucleus, there are functional evidences to suggest that the cytoplasmic immunohistochemical expression represent the phenotypic evidence of protein inactivation similar to that observed in other tumor suppressor genes [36, 37]. This evidence concerns the gene CDKN2A and neoplasm.